文献速递前列腺癌

全民医疗体系中收入状态与前列腺癌治疗选择的相关性:基于人群的分析

The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.
PubMed 文献 · J Urol · 2021-06-28

研究基于加拿大曼尼托巴省2005—2016年非转移性前列腺癌数据库,纳入接受根治性前列腺切除术(RP)或放疗(RT)的3966例患者。调整人口学与临床病理特征后,收入五分位越高,选择RP而非RT的比值比逐步增加(Q2 vs Q1:调整OR 1.40,95%CI 1.01-1.93;Q5 vs Q1:调整OR 2.30,95%CI 1.70-3.12)。

要点

  • 全民医疗体系下,高收入与更高RP选择几率相关。
  • 收入五分位每升高,RP相对RT的调整OR逐级递增。
  • Q5 vs Q1的调整OR为2.30(95%CI 1.70-3.12)。

核心结论

  • 在全民医疗体系中,收入水平越高,局限期前列腺癌患者接受RP而非RT的 odds 逐步增加。

研究设计与样本

  • 基于加拿大曼尼托巴省癌症数据库的回顾性人群分析,纳入2005—2016年诊断为非转移性前列腺癌并接受RP或RT的3966例患者。
  • 社会经济状态以邮政编码对应社区收入五分位(Q1最低至Q5最高)定义,采用多变量logistic回归嵌套模型分析。

主要发现

  • 共识别3966例患者,其中接受RP 2354例、RT 1612例。
  • 调整人口学与临床病理特征后,随收入五分位升高,选择RP而非RT的几率逐步增加。
  • Q2 vs Q1的调整OR为1.40(95%CI 1.01-1.93),Q5 vs Q1的调整OR为2.30(95%CI 1.70-3.12)。

临床怎么用

  • 临床决策中应关注收入状态对局限期前列腺癌治疗选择的影响,识别患者决策时的价值观、优先事项与障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Treatment selection for localized prostate cancer is guided by risk stratification and patient preferences. While socioeconomic status (SES) disparities exist for access to care, less is known about the effect of SES on treatment decision-making. We sought to evaluate whether income status was associated with the treatment selected (radical prostatectomy [RP] vs radiation therapy [RT]) for nonmetastatic prostate cancer in a universal health care system. MATERIALS AND METHODS: All men from Manitoba, Canada who were diagnosed with nonmetastatic prostate cancer between 2005 and 2016 and subsequently treated with RP or RT were identified using a provincial cancer database. SES was defined as neighborhood income by postal code and divided into income quintiles (Q1-Q5, with Q1 the lowest quintile and Q5 the highest). Multivariable logistic regression nested models were used to compare whether SES was associated with treatment type received. RESULTS: We identified 3,966 individuals who were diagnosed with nonmetastatic prostate cancer and were treated with RP (2,354) or RT (1,612). After adjusting for demographic and clinicopathological characteristics, as income quintile increased, men were incrementally more likely to undergo RP than RT (range Q2 vs Q1: adjusted OR 1.40, 95% CI 1.01-1.93; Q5 vs Q1: adjusted OR 2.30, 95% CI 1.70-3.12). CONCLUSIONS: As income levels increased there was a stepwise incremental increase in the odds of receiving RP over RT for localized prostate cancer. These results may inform initiatives to better understand the values, priorities and barriers that patients experience when making treatment decisions in a universal health care system.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Oake JD, Harasemiw O, Tangri N, et al. The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis. J Urol. 2021. PMID: 34181467. doi:10.1097/JU.0000000000001942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。